Teva Pharmaceutical Industries revenue and financials
In the fiscal year ended December 2025, Teva Pharmaceutical Industries reported revenue of $17.26B (+4.32% year over year). Net income was $1.41B, a net margin of 8.2%.
Fiscal year ending in December. Sources and method on the page How we analyse stocks.
At a glance
- Revenue growth
- +4.32%
- 2025 vs 2024
- Net margin
- 8.2%
- 2024: -9.9%
How Teva Pharmaceutical Industries is changing
Calculated from the annual statements; each fiscal year is labelled with the year it ends.
Revenue grew 0.7% a year on average over the last 5 years
Compound annual growth rate: from $16.66B in 2020 to $17.26B in 2025.
Revenue has grown for 3 fiscal years in a row
Each fiscal year compared with the one before, up to 2025.
Operating margin rose from −14.7% to 12.5%
Operating income over revenue, 2022 → 2025: 27.2 percentage points.
Shares outstanding up 6.2% in 5 years
Average diluted shares, 2020 → 2025: with more shares, each one represents a smaller stake in the company (dilution).
Profitable in 2 of 5 fiscal years
Positive net income, fiscal years 2021–2025.
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 17,258 | 16,544 | 15,846 | 14,925 | 15,878 | 16,659 | 16,887 | 18,271 | 21,853 | 21,903 |
| Cost of revenue | 8,320 | 8,481 | 8,200 | 7,952 | 8,284 | 8,933 | 9,351 | 9,975 | 11,237 | 10,250 |
| Gross profit | 8,938 | 8,064 | 7,645 | 6,973 | 7,594 | 7,726 | 7,537 | 8,296 | 10,615 | 11,653 |
| Selling, general and administrative | 3,973 | 3,702 | 3,498 | 3,445 | 3,528 | 3,671 | 3,806 | 4,214 | 4,846 | 4,973 |
| Research and development | 1,013 | 998 | 953 | 98.0 | 967 | 997 | 1,010 | 114 | 175 | 422 |
| Operating income | 2,157 | -303 | 433 | -2,197 | 1,716 | -3,572 | -443 | -1,637 | -17,484 | 2,154 |
| EBIT | 3,952 | 3,373 | 3,185 | 2,662 | 3,079 | 3,055 | 2,716 | 2,947 | 3,979 | 4,921 |
| EBITDA | 4,954 | 4,432 | 4,338 | 3,970 | 4,409 | 4,612 | 4,438 | 4,789 | 6,091 | 6,445 |
| Interest expense | 916 | 1,002 | 1,029 | 930 | 891 | 901 | 822 | 920 | 875 | 546 |
| Pre-tax income | 1,237 | -1,283 | -622 | -3,142 | 667 | -4,267 | -1,279 | -2,667 | -18,382 | 832 |
| Income tax | -180 | 676 | -7.0 | -643 | 211 | -168 | -278 | -195 | -1,933 | 521 |
| Net income | 1,410 | -1,639 | -559 | -2,446 | 417 | -3,990 | -999 | -2,150 | -16,265 | 329 |
| Net income to common shareholders | 1,410 | -1,639 | -559 | -2,446 | 417 | -3,990 | -999 | -2,399 | -16,525 | 68.0 |
| Basic EPS | 1.23 | -1.45 | -0.50 | -2.20 | 0.38 | -3.64 | -0.91 | -2.35 | -16.26 | 0.07 |
| Diluted EPS | 1.21 | -1.45 | -0.50 | -2.20 | 0.38 | -3.64 | -0.91 | -2.35 | -16.26 | 0.07 |
| Average shares (basic) | 1,145 | 1,131 | 1,119 | 1,110 | 1,102 | 1,095 | 1,091 | 1,021 | 1,016 | 955 |
| Average shares (diluted) | 1,163 | 1,131 | 1,119 | 1,110 | 1,107 | 1,095 | 1,091 | 1,021 | 1,016 | 0.0 |
| Dividend per share | — | — | — | — | — | — | — | — | 0.51 | 1.36 |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 4,395 | 4,142 | 3,982 | 4,711 | 4,480 | 4,176 | 3,891 | 4,229 | 4,332 | 4,164 | 3,819 | 4,457 |
| Cost of revenue | 1,955 | 1,989 | 2,011 | 2,056 | 2,176 | 2,074 | 2,014 | 2,109 | 2,183 | 2,140 | 2,048 | 2,041 |
| Gross profit | 2,440 | 2,153 | 1,971 | 2,655 | 2,304 | 2,102 | 1,877 | 2,120 | 2,149 | 2,024 | 1,771 | 2,416 |
| Selling, general and administrative | 1,007 | 1,034 | 1,000 | 1,120 | 973 | 959 | 919 | 952 | 924 | 939 | 886 | 902 |
| Research and development | 297 | 970 | 222 | 267 | 256 | 244 | 247 | 247 | 240 | 269 | 242 | 227 |
| Operating income | 1,204 | 167 | 763 | 1,285 | 1,066 | 894 | 709 | 916 | 983 | 817 | 660 | 1,251 |
| EBIT | 1,204 | 167 | 763 | 1,285 | 1,066 | 894 | 709 | 916 | 983 | 817 | 660 | 1,251 |
| EBITDA | 1,449 | 408 | 1,002 | 1,545 | 1,315 | 1,145 | 953 | 1,185 | 1,242 | 1,076 | 932 | 1,517 |
| Interest expense | 138 | 186 | 191 | 280 | 205 | 220 | 212 | 319 | 225 | 233 | 225 | 328 |
| Pre-tax income | 300 | -455 | 436 | 90.0 | 648 | 204 | 294 | -247 | -321 | -245 | -471 | 508 |
| Income tax | 66.0 | 121 | 67.0 | -390 | 214 | -78.0 | 74.0 | 28.0 | 69.0 | 630 | -52.0 | 41.0 |
| Net income | 233 | -576 | 369 | 480 | 433 | 282 | 214 | -217 | -437 | -846 | -139 | 463 |
| Net income to common shareholders | 233 | -576 | 369 | 480 | 433 | 282 | 214 | -217 | -437 | -846 | -139 | 463 |
| Basic EPS | 0.20 | -0.49 | 0.32 | 0.42 | 0.38 | 0.25 | 0.19 | -0.19 | -0.39 | -0.75 | -0.12 | 0.41 |
| Diluted EPS | 0.20 | -0.49 | 0.31 | 0.41 | 0.37 | 0.24 | 0.18 | -0.19 | -0.39 | -0.75 | -0.12 | 0.40 |
| Average shares (basic) | 1,166 | 1,165 | 1,156 | 1,149 | 1,147 | 1,147 | 1,138 | 1,133 | 1,133 | 1,133 | 1,123 | 1,121 |
| Average shares (diluted) | 1,183 | 1,165 | 1,179 | 1,173 | 1,164 | 1,161 | 1,159 | 1,133 | 1,133 | 1,133 | 1,123 | 1,137 |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 | 2023 | FY to Sep 2023 | FY to Jun 2023 | FY to Mar 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 40,748 | 39,326 | 43,479 | 42,095 | 43,100 | 43,461 | 44,011 | 47,666 | 50,640 | 57,470 |
| Current assets | 13,946 | 12,552 | 12,485 | — | — | — | 12,051 | 12,573 | 13,005 | 13,464 |
| Cash and equivalents | 3,556 | 3,300 | 3,226 | — | — | — | 2,801 | 2,165 | 2,177 | 1,975 |
| Receivables | 3,709 | 3,059 | 3,408 | — | — | — | 3,696 | 4,529 | 4,581 | 5,676 |
| Inventory | 3,179 | 3,007 | 4,021 | — | — | — | 3,833 | 3,818 | 4,403 | 4,422 |
| Net property, plant and equipment | 4,425 | 4,948 | 6,147 | — | — | — | 6,158 | 6,477 | 6,855 | 6,950 |
| Goodwill | 16,000 | 15,147 | 17,177 | — | — | — | 17,633 | 17,633 | 20,624 | 24,846 |
| Other intangible assets | 3,781 | 4,418 | 5,387 | — | — | — | 6,270 | 7,466 | 8,923 | 11,232 |
| Long-term investments | — | — | 8.0 | — | — | — | — | — | — | — |
| Current liabilities | 13,456 | 12,796 | 12,247 | — | — | — | 11,469 | 11,027 | 13,164 | 13,674 |
| Accounts payable | 2,531 | 2,203 | 2,602 | — | — | — | 1,887 | 1,686 | 1,756 | 1,718 |
| Long-term debt | 15,005 | 16,002 | 18,161 | — | — | — | 19,103 | 21,617 | 22,731 | 24,562 |
| Total debt | 17,230 | 18,184 | 20,273 | — | — | — | 21,676 | 23,593 | 26,535 | 27,460 |
| Total liabilities | 32,834 | 33,606 | 35,353 | 34,708 | 35,508 | 34,957 | 35,413 | 36,422 | 39,579 | 42,407 |
| Total equity (incl. minority) | 7,914 | 5,720 | 8,126 | — | — | — | 8,598 | 11,244 | 11,061 | 15,063 |
| Retained earnings | -13,762 | -15,173 | -13,534 | — | — | — | -12,975 | -10,529 | -10,946 | -6,956 |
| Minority interest | 4.0 | 347 | 620 | — | — | — | 794 | 966 | 1,035 | 1,091 |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 40,042 | 39,857 | 40,040 | 40,748 | 39,856 | 40,131 | 38,415 | 39,326 | 41,758 | 41,338 | 42,773 | 43,479 |
| Current assets | 14,602 | 13,760 | 13,710 | 13,946 | 12,736 | 12,620 | 11,528 | 12,552 | 12,314 | 11,632 | 12,297 | 12,485 |
| Cash and equivalents | 4,085 | 3,655 | 3,741 | 3,556 | 2,203 | 2,161 | 1,697 | 3,300 | 3,319 | 2,258 | 2,991 | 3,226 |
| Receivables | 3,837 | 3,493 | 3,393 | 3,709 | 3,810 | 3,564 | 3,384 | 3,059 | 3,462 | 3,766 | 3,456 | 3,408 |
| Inventory | 3,173 | 3,221 | 3,176 | 3,179 | 3,323 | 3,497 | 3,247 | 3,007 | 3,959 | 3,927 | 3,949 | 4,021 |
| Net property, plant and equipment | 4,068 | 4,261 | 4,333 | 4,425 | 5,162 | 5,168 | 4,994 | 4,948 | 6,036 | 5,931 | 5,982 | 6,147 |
| Goodwill | 15,742 | 15,839 | 15,822 | 16,000 | 15,945 | 15,949 | 15,477 | 15,147 | 16,124 | 16,488 | 17,007 | 17,177 |
| Other intangible assets | 3,303 | 3,447 | 3,609 | 3,781 | 3,936 | 4,142 | 4,189 | 4,418 | 4,756 | 4,853 | 5,056 | 5,387 |
| Long-term investments | — | — | — | — | — | — | — | — | — | — | — | 8.0 |
| Current liabilities | 15,425 | 15,646 | 13,532 | 13,456 | 11,491 | 11,861 | 11,157 | 12,796 | 13,797 | 13,037 | 13,792 | 12,247 |
| Accounts payable | 2,551 | 2,721 | 2,596 | 2,531 | 2,355 | 2,498 | 2,290 | 2,203 | 2,371 | 2,366 | 2,439 | 2,602 |
| Long-term debt | 12,694 | 12,112 | 14,033 | 15,005 | 16,784 | 16,782 | 16,230 | 16,002 | 16,400 | 16,547 | 16,584 | 18,161 |
| Total debt | 16,984 | 16,894 | 16,913 | 17,230 | 17,091 | 17,542 | 16,939 | 18,184 | 19,275 | 18,922 | 19,938 | — |
| Total liabilities | 32,058 | 32,100 | 31,808 | 32,834 | 32,602 | 33,297 | 32,146 | 33,606 | 35,374 | 34,775 | 35,230 | 35,353 |
| Total equity (incl. minority) | 7,984 | 7,757 | 8,232 | 7,914 | 7,254 | 6,834 | 6,269 | 5,720 | 6,384 | 6,563 | 7,543 | 8,126 |
| Retained earnings | -13,736 | -13,969 | -13,394 | -13,762 | -14,243 | -14,676 | -14,958 | -15,173 | -14,956 | -14,519 | -13,673 | -13,534 |
| Minority interest | 5.0 | 4.0 | 4.0 | 4.0 | 4.0 | 7.0 | 7.0 | 347 | 319 | 204 | 265 | 620 |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 1,649 | 1,247 | 1,368 | 1,590 | 798 | 1,216 | 748 | 2,446 | 2,225 | 3,890 |
| Depreciation and amortization | 1,002 | 1,059 | 1,153 | 1,308 | 1,330 | 1,557 | 1,722 | 1,842 | 2,112 | 1,524 |
| Capital expenditure | -501 | -498 | -526 | -548 | -562 | -578 | -525 | -651 | -874 | -901 |
| Investing cash flow | 737 | 792 | 968 | 656 | 1,523 | 863 | 1,355 | 1,866 | 3,446 | -34,405 |
| Financing cash flow | -2,151 | -1,791 | -1,913 | -1,487 | -2,172 | -1,885 | -1,926 | -3,351 | -5,750 | 25,217 |
| Dividends paid | — | — | — | — | — | — | -52.0 | -12.0 | -901 | -1,303 |
| Share repurchases | — | — | — | — | — | — | — | — | 0.0 | 0.0 |
| Debt issued | 2,298 | 0.0 | 3,151 | 0.0 | 5,674 | 550 | 2,583 | 4,434 | 506 | 27,250 |
| Debt repaid | -4,112 | -1,641 | -4,852 | -1,369 | -7,840 | -2,430 | -4,446 | -7,706 | -4,983 | -999 |
| Effect of exchange rates | 21.0 | -174 | -30.0 | -123 | -128 | 8.0 | 16.0 | -142 | 54.0 | -660 |
| Net change in cash | 256 | 74.0 | 393 | 636 | 21.0 | 202 | 193 | 819 | -25.0 | -5,958 |
| Free cash flow | 1,148 | 749 | 842 | 1,042 | 236 | — | — | — | — | — |
| Levered free cash flow | 2,032 | 2,623 | 3,298 | 2,900 | 2,307 | 1,764 | 2,128 | 2,837 | 3,530 | 3,137 |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 241 | 411 | -40.0 | 1,158 | 369 | 227 | -105 | 575 | 693 | 103 | -124 | 1,184 |
| Depreciation and amortization | 245 | 241 | 239 | 260 | 249 | 251 | 244 | 269 | 259 | 259 | 272 | 266 |
| Capital expenditure | -120 | -104 | -168 | -142 | -136 | -96.0 | -127 | -129 | -148 | -97.0 | -124 | -119 |
| Investing cash flow | 210 | -491 | 229 | 165 | 135 | 236 | 201 | 202 | 268 | 178 | 144 | 301 |
| Financing cash flow | 6.0 | -1.0 | 13.0 | 40.0 | -453 | 6.0 | -1,744 | -674 | — | -966 | -151 | -576 |
| Debt issued | 4,845 | 0.0 | — | 0.0 | — | 2,305 | — | — | — | — | — | — |
| Debt repaid | -4,883 | 0.0 | -23.0 | 0.0 | -444 | -2,300 | -1,368 | -685 | — | -956 | — | -500 |
| Effect of exchange rates | -27.0 | -5.0 | -17.0 | -10.0 | -9.0 | -5.0 | 45.0 | -121 | 100 | -49.0 | -104 | 68.0 |
| Net change in cash | 430 | -86.0 | 185 | 1,353 | 42.0 | 464 | -1,603 | -18.0 | 1,061 | -733 | -236 | 977 |
| Free cash flow | 121 | 307 | -208 | 1,016 | 233 | 131 | -232 | 446 | 545 | 6.0 | -248 | 1,065 |
| Levered free cash flow | 612 | 255 | 271 | 1,015 | 669 | 647 | -309 | 1.1 | 1,267 | 702 | 655 | 1,232 |
Financial statements of similar companies
Companies in the group: same industry, similar size
